Skip to main content
KindleeRx logoStart
AI illustration of a woman pausing over breakfast beside a glass of water and a tablet.

AI-generated illustration. Not an actual patient or treatment result.

Nail CareNovember 19, 2026 · 9 min read

Terbinafine Side Effects: How Common Are They?

Dr. Brandon Kirsch
Dr. Brandon Kirsch, MD, FAAD

Chief Medical Officer

Most people who take terbinafine have no side effects or mild ones, and each side effect runs only a few points above placebo. Among 25,884 patients in postmarketing studies, 10.5% reported any adverse event, mostly stomach or skin complaints (Hall 1997). In the label's three trials (465 people on terbinafine, 137 on placebo), the effects were mostly mild and short-lived and rarely led anyone to stop (terbinafine prescribing information). The rare ones worth knowing are taste or smell loss, mood changes, serious rashes and liver injury.

In this article

What are the most common side effects of terbinafine?

The most common side effects are headache, diarrhea, rash and indigestion, each only slightly more frequent than on placebo. Nausea (2.6% vs 2.9%) and gas (2.2% vs 2.2%) were no more common than on placebo. No single side effect made more than 0.9% of people stop the drug (terbinafine prescribing information). In the 504-person IRON-CLAD trial, 2.8% stopped for a side effect (Tavakkol 2006). A Cochrane review found no clear difference: an estimated 48 in 100 on terbinafine and 43 in 100 on placebo reported any health problem (Kreijkamp-Kaspers 2017).

Side effectTerbinafine (n = 465)Placebo (n = 137)Stopped terbinafine for it
Headache12.9%9.5%0.2%
Diarrhea5.6%2.9%0.6%
Rash5.6%2.2%0.9%
Indigestion (dyspepsia)4.3%2.9%0.4%
Liver enzymes 2 times normal or higher3.3%1.4%0.2%
Itching2.8%1.5%0.2%
Taste disturbance2.8%0.7%0.2%
Visual disturbance1.1%1.5%0.9%

Source: Table 1 of the terbinafine prescribing information, three US and Canadian placebo-controlled trials.

How common is taste or smell loss on terbinafine, and does it come back?

Taste loss affected 2.8% of people in the label's trials (0.7% on placebo), and taste usually returns, though not always. In a UK cohort of 9,879 people, 0.6% reported it, and recovery took a median of 42 days after stopping (O'Sullivan 1996). In 87 Dutch cases, it started a mean of 35 days in, most people recovered within 4 months, and people aged 65 or older were about 4 times as likely to lose taste as people under 35 (Stricker 1996). The label warns it can cause weight loss, anxiety and depressive symptoms, can last more than a year or be permanent, and says to stop the drug when it starts. Smell loss carries the same label warning, with no frequency given. Self-report may undercount taste loss: formal testing of 6 patients found real loss of sweet, sour and bitter taste (Doty 2005).

Can terbinafine cause depression or mood changes?

Yes, rarely. The label lists depressive symptoms and anxiety from postmarketing reports, sometimes without any taste change (terbinafine prescribing information). In some reports the symptoms eased when the drug was stopped and came back when it was restarted. The label gives no rate, since these are voluntary reports. If you already live with depression or anxiety, tell your prescriber before you start, and report any new low mood right away. I would stop the pills and reassess before pushing through.

Does terbinafine cause weight gain?

Weight gain is not listed as a side effect in the US terbinafine label. The only weight effect it names is weight loss, which happens when taste loss makes people eat less (terbinafine prescribing information). The Medication Guide tells you to report poor appetite or weight loss along with any change in taste (terbinafine Medication Guide). Steady weight loss with a change in taste is a reason to stop and call your prescriber.

Can terbinafine trigger a rash, psoriasis or lupus?

Yes. A rash is the most common skin reaction (5.6% vs 2.2% on placebo). Serious reactions appear only in postmarketing reports, with no rate given. The label lists Stevens-Johnson syndrome, toxic epidermal necrolysis and drug reaction with eosinophilia and systemic symptoms (DRESS) among postmarketing reports, plus psoriasis flares, sun sensitivity and hair loss, and says to stop for a progressive rash. In 4 case reports, psoriasis began or flared 12 to 27 days after starting and improved after stopping the drug and starting psoriasis treatment (Gupta 1997). The label also warns that terbinafine can trigger or worsen lupus. In 37 published cases of terbinafine-induced skin lupus, onset came at a median of 5 weeks, and symptoms cleared a median of 35 days after stopping the drug and starting lupus treatment (He 2025). If you have lupus or psoriasis, raise it before you start.

How rare is liver damage from terbinafine?

Serious liver injury is rare. NIH LiverTox estimates clinically apparent injury at 1 in 2,500 to 1 in 25,000 people exposed, usually in the first 6 weeks, with most cases resolving within 3 to 6 months of stopping (NIH LiverTox). The label says terbinafine should not be used with chronic or active liver disease, says to check liver tests before starting and periodically during treatment, and reports liver failure, some cases fatal or needing transplant. Before prescribing oral terbinafine, your clinician may ask for copies of your earlier liver blood test results, or ask your primary care provider to order a test.

When should you stop terbinafine?

Stop terbinafine and contact your prescriber if you notice any of these, each a stop instruction in the label (terbinafine prescribing information):

  • A change in or loss of taste.
  • A change in or loss of smell.
  • A rash that keeps spreading.
  • New or worsening lupus.
  • Any of the liver warning signs above.
  • A neutrophil (white blood cell) count of 1,000 or lower, if your blood is checked.

Report new low mood or anxiety right away as well; the label warns about both. Get emergency help for hives, mouth sores, blistering or peeling skin, swelling of the face, eyes, lips, tongue or throat, trouble swallowing or breathing, fever, or swollen glands. Report unexplained bleeding or bruising right away, a possible sign of a rare clotting problem called thrombotic microangiopathy (terbinafine Medication Guide). The label describes trial side effects such as headache and upset stomach as generally mild and short-lived.

How does KindleeRx use terbinafine?

KindleeRx offers a 90-day prescription nail program that pairs oral terbinafine with a compounded topical antifungal when a clinician decides it is appropriate. The oral part is terbinafine 250 mg once daily for one week each month, 21 tablets over 3 months, which differs from the label's 12 weeks of daily dosing (84 tablets). The topical is a 30 mL compounded solution with itraconazole 1%, terbinafine 3%, urea 20% and tea tree oil 6.6%; compounded medications are not FDA-approved. Licensed clinicians (physician assistants and nurse practitioners working under a board-certified dermatologist's protocols) review your medicines and history, prescribe only when appropriate, and reply in under 5 hours on average. Not everyone qualifies; if nothing is prescribed, the refund is full, including the consultation fee. The first order with automatic refills is $99, before coupons.

For how pills compare with topicals, read oral vs topical toenail fungus treatment. For when an in-person visit makes more sense, read do you need a doctor for toenail fungus. The complete guide to toenail fungus covers the rest.

Sources

Related Articles